- Article
Persistence of Second and Third-Line Biologics in Inflammatory Bowel Disease: A Multi-Centre Cohort Study
- Timothy P. Hanrahan,
- Robbie Chan,
- Daniel Tassone,
- Nik S. Ding,
- Chamara Basnayake,
- Julien Schulberg,
- Abhinav Vasudevan,
- Michael Kamm,
- Michael De Gregorio and
- Daniel R. van Langenberg
- + 1 author
16 December 2022
Background: Despite proven efficacy of biologics in inflammatory bowel disease (IBD), many exhibit primary non-response or secondary loss of response and switch to subsequent biologic(s). Here, we identified early predictors of second- and/or third-l...

